متابعة
Oskar Hansson
Oskar Hansson
Professor of Neurology, Lund University
بريد إلكتروني تم التحقق منه على med.lu.se - الصفحة الرئيسية
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study‏
O Hansson, H Zetterberg, P Buchhave, E Londos, K Blennow, L Minthon‏
The Lancet Neurology 5 (3), 228-234, 2006‏
21832006
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment‏
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...‏
Jama 302 (4), 385-393, 2009‏
14782009
Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial‏
JR Sims, JA Zimmer, CD Evans, M Lu, P Ardayfio, JD Sparks, AM Wessels, ...‏
Jama 330 (6), 512-527, 2023‏
11352023
Brain charts for the human lifespan‏
RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ...‏
Nature 604 (7906), 525-533, 2022‏
10712022
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts‏
TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ...‏
The Lancet Neurology 19 (5), 422-433, 2020‏
10562020
Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders‏
S Palmqvist, S Janelidze, YT Quiroz, H Zetterberg, F Lopera, E Stomrud, ...‏
Jama 324 (8), 772-781, 2020‏
10412020
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia‏
S Janelidze, N Mattsson, S Palmqvist, R Smith, TG Beach, GE Serrano, ...‏
Nature medicine 26 (3), 379-386, 2020‏
10192020
Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease‏
S Budd Haeberlein, PS Aisen, F Barkhof, S Chalkias, T Chen, S Cohen, ...‏
The journal of prevention of Alzheimer's disease 9 (2), 197-210, 2022‏
9632022
Cerebrospinal fluid levels ofβ-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia‏
P Buchhave, L Minthon, H Zetterberg, ÅK Wallin, K Blennow, O Hansson‏
Archives of general psychiatry 69 (1), 98-106, 2012‏
8192012
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity‏
S Palmqvist, M Schöll, O Strandberg, N Mattsson, E Stomrud, H Zetterberg, ...‏
Nature communications 8 (1), 1214, 2017‏
8042017
Biomarkers for neurodegenerative diseases‏
O Hansson‏
Nature medicine 27 (6), 954-963, 2021‏
7942021
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease‏
MM Zeron, O Hansson, N Chen, CL Wellington, BR Leavitt, P Brundin, ...‏
Neuron 33 (6), 849-860, 2002‏
7482002
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers‏
GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ...‏
The Lancet Neurology 16 (8), 661-676, 2017‏
6962017
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation‏
CE Teunissen, IMW Verberk, EH Thijssen, L Vermunt, O Hansson, ...‏
The Lancet Neurology 21 (1), 66-77, 2022‏
6792022
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis‏
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...‏
JAMA neurology 76 (9), 1035-1048, 2019‏
6692019
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts‏
O Hansson, J Seibyl, E Stomrud, H Zetterberg, JQ Trojanowski, T Bittner, ...‏
Alzheimer's & dementia 14 (11), 1470-1481, 2018‏
6542018
Plasma β-amyloid in Alzheimer’s disease and vascular disease‏
S Janelidze, E Stomrud, S Palmqvist, H Zetterberg, D Van Westen, ...‏
Scientific reports 6 (1), 26801, 2016‏
6462016
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity‏
D Lindqvist, S Janelidze, P Hagell, S Erhardt, M Samuelsson, L Minthon, ...‏
Biological psychiatry 66 (3), 287-292, 2009‏
5982009
CSF and blood biomarkers for Parkinson's disease‏
L Parnetti, L Gaetani, P Eusebi, S Paciotti, O Hansson, O El-Agnaf, ...‏
The Lancet Neurology 18 (6), 573-586, 2019‏
5932019
Four distinct trajectories of tau deposition identified in Alzheimer’s disease‏
JW Vogel, AL Young, NP Oxtoby, R Smith, R Ossenkoppele, ...‏
Nature medicine 27 (5), 871-881, 2021‏
5872021
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20